Lewicki Jędrzej, Religioni Urszula, Merks Piotr
Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
Collegium of Business Administration, Warsaw School of Economics, Warsaw, Poland.
Patient Prefer Adherence. 2021 Jul 17;15:1611-1619. doi: 10.2147/PPA.S312341. eCollection 2021.
Evaluation of the implementation of pharmaceutical services to detect comorbidities in at-risk patients.
This study was carried out in community pharmacies across Poland in 2019 inside the specially designed service "Refer the Patient". The project was intended for patients with selected chronic diseases. The patients were identified on the basis of their medications (active substances). At-risk patients were referred for prophylactic examinations to detect comorbidities.
A total of 78 pharmacies took part in this study and 209 at-risk patients were identified. Out of the patients referred for examinations, 30% had deviant results, and 0.95% were diagnosed with new diseases.
Pharmaceutical services supporting screening tests among at-risk patients are highly recommended. Pharmacist intervention allows for early detection of comorbidities and prompt treatment. The pharmaceutical service "Refer the Patient" makes it possible to detect a disease at an early stage. Rapid implementation of treatment can prevent serious health consequences, maintains patient quality of life, and reduce treatment costs.
评估药学服务在高危患者中检测合并症的实施情况。
2019年，在波兰各地的社区药房开展了一项名为“转诊患者”的专门设计服务。该项目针对患有特定慢性病的患者。根据患者所服用的药物（活性成分）来识别患者。高危患者被转介进行预防性检查以检测合并症。
共有78家药房参与了本研究，识别出209名高危患者。在被转介进行检查的患者中，30%的检查结果异常，0.95%被诊断出患有新疾病。
强烈建议在高危患者中开展支持筛查测试的药学服务。药师干预能够早期发现合并症并及时进行治疗。“转诊患者”药学服务能够在疾病早期进行检测。迅速实施治疗可以预防严重的健康后果，维持患者生活质量并降低治疗成本。
